BCM
JNCE

BML Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

BML Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,087,961
Closed -$2.01M – 36
2023
Q1 		$2.01M Buy
+1,087,961
New +$2.01M 1.74% 18